Holen Sie sich die Stockscreener-App
19.58
1.36%
-0.27
Handel nachbörslich:
19.40
-0.18
-0.92%
Schrodinger Inc Aktie (SDGR) Neueste Nachrichten
Schrödinger (SDGR) Q2 2026 Earnings Call Transcript - AOL.com
Schrodinger (NASDAQ:SDGR) Trading 10.4% HigherWhat's Next? - MarketBeat
BMO Capital Maintains Schrodinger(SDGR.US) With Buy Rating, Maintains Target Price $24 - Moomoo
The Zacks Analyst Blog Highlights Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci - Zacks Investment Research
Schrodinger Inc. (SDGR) Slides 4.7% to $17.59 as Bearish Momentum BuildsCounter Trend Trade - Vinanet
SDGR Looks 29.7% Undervalued on GF Value™ - GuruFocus
symbol__ Stock Quote Price and Forecast - CNN
Schrodinger (SDGR) Slides 4.7% to $17.59 as Selling Pressure MountsSynthetic Short - Vinanet
Schrodinger Inc (SDGR) Stock Down 4.8% -- Now Undervalued? GF Sc - GuruFocus
UBS initiates Schrodinger stock coverage with neutral rating By Investing.com - Investing.com South Africa
SDGR Assumed by UBS -- Price Target Raised to $19.00 - GuruFocus
UBS Maintains Schrodinger(SDGR.US) With Hold Rating, Maintains Target Price $19 - Moomoo
Schrodinger Coverage Assumed by UBS at Neutral - Moomoo
UBS Adjusts Schrodinger PT to $19 From $13, Maintains Neutral Rating - marketscreener.com
Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView
Two New Schrödinger Hires Get Stock Awards Vesting Over Four Years - Stock Titan
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
UBS initiates Schrodinger stock coverage with neutral rating - Investing.com Nigeria
UBS Initiates Schrodinger(SDGR.US) With Hold Rating, Announces Target Price $19 - Moomoo
Schrodinger, Inc. Stock 12‑Month Price Target Raised to $21.83, Implies 18% Upside - TradingView
Analysts’ Opinions Are Mixed on These Healthcare Stocks: AIM ImmunoTech (AIM) and Schrodinger (SDGR) - The Globe and Mail
Schrodinger, Inc. (SDGR) Stock Forecasts - Yahoo! Finance Canada
Quantinno Capital Management LP Buys Shares of 174,095 Schrodinger, Inc. $SDGR - MarketBeat
Schrödinger (SDGR) Is Up 19.2% After AI Pact With BMS And Q2 ProfitabilityHas The Bull Case Changed? - simplywall.st
Schrödinger Unveils Bunsen, an AI Co-Scientist for Enhanced Molecular Discovery - SynBioBeta
SDGR Q2 2026 Earnings: EPS of $0.08 Beats Estimates with a 116.27% SurpriseReturn On Capital - Vinanet
Dimensional Fund Advisors LP Cuts Holdings in Schrodinger, Inc. $SDGR - MarketBeat
Results: Schrödinger, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - webull.com
The Bull Case For Bristol Myers Squibb (BMY) Could Change Following Expanded Schrödinger Bunsen AI Partnership - Sahm
Schrödinger, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - Moomoo
Schrodinger (NASDAQ:SDGR) Raised to "Hold" at Wall Street Zen - MarketBeat
Schrodinger Inc (SDGR) Stock Analysis & Forecast - TradingKey
Schrodinger Inc (SDGR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Schrodinger Inc. (SDGR) Dips 0.95% to $17.64 as Shares Sit Between Support and ResistanceHigh Low Breadth - dars.gov.et
Schrödinger expands partnership with Bristol Myers Squibb - Investing.com Nigeria
BofA Securities Maintains Schrodinger(SDGR.US) With Buy Rating - Moomoo
TD Cowen Maintains Schrodinger(SDGR.US) With Buy Rating, Maintains Target Price $20 - Moomoo
Schrodinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery - marketscreener.com
Schrödinger Q2 2026 slides: AI launch, Ajax milestone drive beat By Investing.com - Investing.com South Africa
Schrödinger, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:SDGR) 2026-08-06 - Seeking Alpha
SDGR Looks 36.9% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus
Schrodinger Q2 Earnings Call Highlights - MarketBeat
SDGR SWOT Analysis: Key Financial Insights from 10-Q Filing - GuruFocus
Schrodinger Inc (SDGR) (Q2 2026) Earnings Call Highlights: ACV S - GuruFocus
Schrödinger (SDGR) Is Up 8.5% After AI Co‑Scientist Deal With BMS And Q2 Profitability Shift – Has The Bull Case Changed? - Yahoo Finance
Schrodinger Inc (SDGR) (Q2 2026) Earnings Call Highlights: ACV Surges 27% on Bunsen Launch and ... - Yahoo! Finance Canada
Earnings call transcript: Schrödinger beats Q2 2026 forecasts as shares rise - Investing.com South Africa
Schrodinger (NASDAQ:SDGR) Announces Quarterly Earnings Results - marketbeat.com
Schrodinger, Inc. (SDGR) Q2 Earnings and Revenues Top Estimates - Yahoo Finance
Schrödinger : Schrödinger 2Q26 Supplemental Slides - marketscreener.com
Is Schrodinger Inc (SDGR) Undervalued After Q2 Earnings Reveal $58.9 Million Revenue? GF Score: 73/100 - GuruFocus
Schrodinger Inc reports results for the quarter ended June 30Earnings Summary - TradingView
SDGR: Q2 2026 delivered 27% ACV growth, $58.9M revenue, and accelerated AI-driven innovation - TradingView
Q2 2026 Schrodinger Inc Earnings Call Transcript - GuruFocus
Schrodinger Q2 revenue beats estimates, swings to profit - TradingView
SDGR: 2Q26 revenue up 7.5% year-over-year, with drug discovery revenue surging 65% - TradingView
1.35%
2.79%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):